Medico Remedies Ltd

Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we hereby inform you that the Board of Directors of our company at their meeting held today i.e. 10th August 2023 has inter alia considered and approved the Quarterly Unaudited Standalone Financial Results for the quarter ended 30th June 2023 along with the Limited Review Report thereon.